Karnataka Court orders Rs 13 lakh compensation for nurse over faulty Hepatitis report
UDUPI : A senior nurse from Udupi, 43-year-old Shivakumar Shettigar, lost a job opportunity in Saudi Arabia after a diagnostic error wrongly indicated he had hepatitis C. The faulty report was issued by National CT Scanner and Diagnostic Centre, Mangaluru.
Shettigar later tested negative at different facilities and approached the Udupi district Consumer Disputes Redressal Commission, alleging negligence. The court ruled in his favour, holding the diagnostic centre accountable for the career loss and mental trauma caused. The court has ordered the centre to pay a compensation of Rs 13.49 lakh to Shettigar within 45 days.
Shettigar told TNIE that he was selected for the post of industrial nurse at United Medical Response Company, Saudi Arabia. He was scheduled to travel in February 2024. As part of the mandatory medical clearance required by the Gulf Cooperation Council (GCC), he underwent a test at GCC notified lab -- National CT Scanner and Diagnostic Centre, Mangaluru, on January 17, 2024.
The test falsely showed he was Hepatitis C positive. Shettigar underwent a test the next day at a private lab in Manipal, where the results came back negative. Within a week, he also underwent another test at the district government hospital in Udupi and again tested negative.
He alleged that the diagnostic centre in Mangaluru had used a faulty kit and the equipment was not properly maintained.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Wegovy, the global weight loss drug, launched in India: How much will it cost?
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in India. This adds to the option of weight loss drugs in India, with Eli Lilly's injectable Mounjaro now also available in the country. The product, which is a prescription medicine, will be sold as an injectable and marketed as a 'skinny jab.' The delivery device will contain four doses. The 0.25 mg, 0.5 mg, and 1 mg doses will be priced at Rs 17,345, translating to a weekly cost of Rs 4,366. The 1.7 mg dose will be priced at Rs 24,280 per month, while the 2.4 mg dose will be priced at Rs 26,015, the company announced. How is Wegovy different from Ozempic and Mounjaro? Wegovy is made of semaglutide, a GLP 1A receptor agonist, which mimics the effects of the naturally occurring hormone GLP-1, which helps regulate blood sugar, reduce appetite and slow down gastric emptying. Wegovy is approved for weight loss, but only if you are above a certain weight. Ozempic (also semaglutide) is used more for diabetes management. The main difference between the two is the dose since they are the same drug and taken in the same way. Mounjaro is made up of tirzepatide, which mimics the function of natural hormones GIP and GLP-1. It has a double effect, of increasing insulin secretion in response to food intake and improving glucose control and weight loss. It is officially approved for Type 2 diabetes and weight loss in people with obesity or overweight plus related health conditions. What makes Wegovy special? Studies have shown an unprecedented weight loss in users by almost 10 to 15 per cent. What are the benefits of Wegovy? It has been found to have more benefits than just weight loss. A study has now shown that the drug helps people with diabetes deal with a common kind of obesity-related heart failure. Obese people have elevated blood sugar levels and enlarged hearts, which increase the risk of heart failure. Wegovy helps curb hunger by slowing down movement of food from the stomach into the small intestine. So you feel full, eat less and control your fatty liver too. Studies have shown it can also bring down blood pressure and cholesterol and slow down the progression of chronic kidney disease, preventing mortality from related complications.
Business Standard
2 hours ago
- Business Standard
Country Delight Launches Oats Beverage - A Wholesome, Affordable Plant-Based Alternative
VMPL New Delhi [India], June 24: Country Delight has announced the launch of its all-new Oats Beverage, marking its foray into the rapidly growing plant-based drink segment. Designed for health-conscious consumers seeking a nutritious and affordable alternative, Country Delight's Oats beverage is crafted with the same commitment to purity, quality, and freshness that the brand is known for. Shift in Consumer Preference: Oat and Plant-Based Drink Gain Momentum India's widespread lactose intolerance affecting a vast number of the population meets its match in the affordable oats beverage - a smooth, lactose-free alternative that does not compromise on taste. With increasing consumer demand for plant-based alternatives, Country Delight's Oats Beverage is set to redefine the segment with its rich in taste and unmatched nutritional benefits. Made from high-quality Australian oats and free from chemical additives, preservatives, and added sugars, this product contains fiber, vitamins, and minerals, making it an ideal choice for lactose-intolerant individuals, fitness enthusiasts, and health-conscious consumers. Mr. Chakradhar Gade, CEO & Co-Founder, Country Delight, said, "At Country Delight, we are constantly innovating to meet the evolving needs of our consumers. With the launch of Oats Beverage, we aim to provide a nutritious, plant-based alternative without compromising on taste or quality. Our mission has always been to make India live better, and this product is another step towards offering wholesome, nutritious food choices". Key Features of Country Delight Oats Beverage Country Delight's Oats Beverage offers a range of benefits that make it a smart and wholesome choice for today's health-conscious consumers. It is naturally lactose-free, making it ideal for people with lactose intolerance who often struggle with digestive sensitivity. This oats beverage is easy on the stomach and supports better digestion thanks to the presence of soluble fiber (beta-glucan) and the absence of lactose or casein--common culprits behind bloating and discomfort. Unlike many other plant-based drinks that rely on common allergens like soy or nuts, Country Delight's Oats Beverage is free from both. The product is also free from added sugar and preservatives. It is completely unsweetened, with no artificial sweeteners, allowing consumers to enjoy a, minimally processed plant-based drink. Combining purity with quality, this oat beverage aligns with Country Delight's promise of delivering fresh, nutritious, and trustworthy products to Indian households. Country Delight's Oats Beverage is priced at Rs. 40 for a 400ml pack and will be available for order through the Country Delight app. (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
Time of India
2 hours ago
- Time of India
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details
A month after rival Eli Lilly's launch, Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week injection in Danish company hopes for massive sales in India, a country where nearly 254 million people are struggling due to generalised obesity and 351 million with abdominal obesity. Novo Nordisk's ambitious sales of $1 billion in coming years stems from its estimate that a significant proportion of them are potential users of such drugs, given the additional benefits to the heart, liver and 0.25 mg, 0.5 mg, and 1 mg injection pens are priced at Rs 17,345 each, translating to Rs 4,366 per dose.(more to come)
